Trial intelligence / Profile preview

Sumac (Rhus coriaria L.) capsules vs mefenamic acid for menorrhagia

IRCT20181024041449N6Phase 3Completed

Sponsor
Shahrekord University of Medical Sciences
Start
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of rhus coriaria and Mefenamic acid in hypermenorrhea (2 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoints: Change in menstrual bleeding amount and Change in quality of life. Started Dec 2016; status: completed.

02

Drugs

rhus coriariaMefenamic acid
03

Conditions

hypermenorrhea

Beyond the preview

Go deeper on IRCT20181024041449N6.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20181024041449N6.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call